Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer
ConclusionsDCF-R treatment for advanced cervical esophageal cancer could be completed by the careful administration; although a strong blood toxicity might occur, this treatment may provide the chance to obtain favorable prognosis with larynx preservation.
Source: Esophagus - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Docetaxel | Esophagus Cancer | Laryngeal Cancer | Pain | Pharyngeal Cancer | Skin Cancer | Squamous Cell Carcinoma | Study | Taxotere | Thyroid | Thyroid Cancer | Toxicology | Tracheal Cancer